Skip to content

In the News: The Risks and Rewards of Decentralized Clinical Trials

DCTs completely revise historical trial processes by executing trials through telemedicine and mobile or local health care providers. Although COVID increased the need for DCTs, 75% of the industry report very little use of decentralized and virtual trials. Read more from Dario Lirio, Senior Director, LifeSphere Clinical, over on PharmaLive.

ArisGlobal Launches LifeSphere NavaX™   Learn More

Join us at Breakthrough 2024 to explore life sciences transformation through Intelligent Automation

Registration is closed!